These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10547427)

  • 21. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses.
    Santra S; Barouch DH; Jackson SS; Kuroda MJ; Schmitz JE; Lifton MA; Sharpe AH; Letvin NL
    J Immunol; 2000 Dec; 165(12):6791-5. PubMed ID: 11120800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Induction of cytotoxic T cell responses in mice by immunization with multi-CTL epitope-based anti-HCV DNA vaccine].
    Shi L; Liu S; Sheng L; Meng ZJ; Yuan YK
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):385-6. PubMed ID: 16732921
    [No Abstract]   [Full Text] [Related]  

  • 23. Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.
    Guan J; Deng Y; Chen H; Yin X; Yang Y; Tan W
    Arch Virol; 2015 Oct; 160(10):2517-24. PubMed ID: 26215441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.
    Kuhöber A; Pudollek HP; Reifenberg K; Chisari FV; Schlicht HJ; Reimann J; Schirmbeck R
    J Immunol; 1996 May; 156(10):3687-95. PubMed ID: 8621903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.
    Shirai M; Chen M; Arichi T; Masaki T; Nishioka M; Newman M; Nakazawa T; Feinstone SM; Berzofsky JA
    J Infect Dis; 1996 Jan; 173(1):24-31. PubMed ID: 8537666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model.
    Wedemeyer H; Gagneten S; Davis A; Bartenschlager R; Feinstone S; Rehermann B
    Gastroenterology; 2001 Nov; 121(5):1158-66. PubMed ID: 11677208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [DNA vaccination of the induction of immune responses by codelivery of IL-12 expression vector with hepatitis C structural antigens].
    Shan M; Liu K; Fang H
    Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):236-9. PubMed ID: 10715797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus precore protein augments genetic immunizations of the truncated hepatitis C virus core in BALB/c mice.
    Liao G; Wang Y; Chang J; Bian T; Tan W; Sun M; Li W; Yang H; Chen J; Zhang X; Bi S; Omata M; Jiang S
    Hepatology; 2008 Jan; 47(1):25-34. PubMed ID: 18074356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O.
    Cornell KA; Bouwer HG; Hinrichs DJ; Barry RA
    J Immunol; 1999 Jul; 163(1):322-9. PubMed ID: 10384131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model.
    Encke J; zu Putlitz J; Geissler M; Wands JR
    J Immunol; 1998 Nov; 161(9):4917-23. PubMed ID: 9794426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids.
    Geissler M; Gesien A; Wands JR
    J Immunol; 1997 Nov; 159(10):5107-13. PubMed ID: 9366440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes.
    Fomsgaard A; Nielsen HV; Kirkby N; Bryder K; Corbet S; Nielsen C; Hinkula J; Buus S
    Vaccine; 1999 Nov; 18(7-8):681-91. PubMed ID: 10547428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
    Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A truncated variant of the hepatitis C virus core induces a slow but potent immune response in mice following DNA immunization.
    Dueñas-Carrera S; Alvarez-Lajonchere L; Alvarez-Obregón JC; Herrera A; Lorenzo LJ; Pichardo D; Morales J
    Vaccine; 2000 Nov; 19(7-8):992-7. PubMed ID: 11115726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene.
    Frelin L; Ahlén G; Alheim M; Weiland O; Barnfield C; Liljeström P; Sällberg M
    Gene Ther; 2004 Mar; 11(6):522-33. PubMed ID: 14999224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.
    Vidalin O; Fournillier A; Renard N; Chen M; Depla E; Boucreux D; Brinster C; Baumert T; Nakano I; Fukuda Y; Liljeström P; Trépo C; Inchauspé G
    Virology; 2000 Oct; 276(2):259-70. PubMed ID: 11040118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
    Geissler M; Gesien A; Tokushige K; Wands JR
    J Immunol; 1997 Feb; 158(3):1231-7. PubMed ID: 9013964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles.
    Brinster C; Chen M; Boucreux D; Paranhos-Baccala G; Liljeström P; Lemmonier F; Inchauspé G
    J Gen Virol; 2002 Feb; 83(Pt 2):369-381. PubMed ID: 11807230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and immune response to hepatitis C virus core gene combined hepatitis B virus core gene with two multiple cloning sites vector].
    Deng T; Fan G; Chen T; Chen N; Hu D; Wang M; Jia K
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(2):77-80. PubMed ID: 11953132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses.
    Ren Y; Min YQ; Liu M; Chi L; Zhao P; Zhang XL
    Biochim Biophys Acta; 2016 Aug; 1860(8):1764-75. PubMed ID: 26278021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.